PMID- 37660839 OWN - NLM STAT- MEDLINE DCOM- 20231102 LR - 20231102 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 208 DP - 2023 Nov 1 TI - Macrophage CAPN4 regulates CVB3-induced cardiac inflammation and injury by promoting NLRP3 inflammasome activation and phenotypic transformation to the inflammatory subtype. PG - 430-444 LID - S0891-5849(23)00612-3 [pii] LID - 10.1016/j.freeradbiomed.2023.08.032 [doi] AB - Exploring the immune mechanism of coxsackievirus B3 (CVB3)-induced myocarditis may provide a promising therapeutic strategy. Here, we investigated the regulatory role of macrophage CAPN4 in the phenotypic transformation of macrophages and NOD-like receptor protein 3 (NLRP3) inflammasome activation. We found that CAPN4 was the most upregulated subtype of the calpain family in CVB3-infected bone marrow-derived macrophages (BMDMs) and Raw 264.7 cells after CVB3 infection and was upregulated in cardiac macrophages from CVB3-infected mice. Conditional knockout of CAPN4 (CAPN4(flox/flox); LYZ2-Cre, CAPN4-cKO mice) ameliorated inflammation and myocardial injury and improved cardiac function and survival after CVB3 infection. Enrichment analysis revealed that macrophage differentiation and the interleukin signaling pathway were the most predominant biological processes in macrophages after CVB3 infection. We further found that CVB3 infection and the overexpression of CAPN4 promoted macrophage M1 polarization and NLRP3 inflammasome activation, while CAPN4 knockdown reversed these changes. Correspondingly, CAPN4-cKO alleviated CVB3-induced M1 macrophage transformation and NLRP3 expression and moderately increased M2 transformation in vivo. The culture supernatant of CAPN4-overexpressing or CVB3-infected macrophages impaired cardiac fibroblast function and viability. Moreover, macrophage CAPN4 could upregulate C/EBP-homologous protein (chop) expression, which increased proinflammatory cytokine release by activating the phosphorylation of transducer of activator of transcription 1 (STAT1) and 3 (STAT3). Overall, these results suggest that CAPN4 increases M1-type and inhibits M2-type macrophage polarization through the chop-STAT1/STAT3 signaling pathway to mediate CVB3-induced myocardial inflammation and injury. CAPN4 may be a novel target for viral myocarditis treatment. CI - Copyright (c) 2023 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Wang, Yucheng AU - Wang Y AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Li, Minghui AU - Li M AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Chen, Jun AU - Chen J AD - The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310000, Zhejiang, China. FAU - Yu, Ying AU - Yu Y AD - Department of General Practice, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Yu, Yong AU - Yu Y AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Shi, Hui AU - Shi H AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Liu, Xiaoxiao AU - Liu X AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Chen, Zhiwei AU - Chen Z AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. FAU - Chen, Ruizhen AU - Chen R AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. Electronic address: chen.ruizhen@zs-hospital.sh.cn. FAU - Ge, Junbo AU - Ge J AD - Key Laboratory of Viral Cardiovascular Diseases, Ministry of Health, China & Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Xuhui District, Shanghai, 200010, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230901 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Inflammasomes) RN - 0 (NLR Family, Pyrin Domain-Containing 3 Protein) RN - 0 (NLR Proteins) SB - IM MH - Animals MH - Mice MH - *Coxsackievirus Infections/genetics/metabolism MH - Enterovirus B, Human/metabolism MH - *Inflammasomes/metabolism MH - Inflammation/genetics/metabolism MH - Macrophages/metabolism MH - *Myocarditis/genetics/metabolism MH - NLR Family, Pyrin Domain-Containing 3 Protein/genetics/metabolism MH - NLR Proteins/metabolism OTO - NOTNLM OT - Calpain OT - Chop OT - Macrophage polarization OT - NLRP3 inflammasome OT - Viral myocarditis COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/09/04 00:41 MHDA- 2023/10/23 00:43 CRDT- 2023/09/03 19:26 PHST- 2023/06/26 00:00 [received] PHST- 2023/08/31 00:00 [revised] PHST- 2023/08/31 00:00 [accepted] PHST- 2023/10/23 00:43 [medline] PHST- 2023/09/04 00:41 [pubmed] PHST- 2023/09/03 19:26 [entrez] AID - S0891-5849(23)00612-3 [pii] AID - 10.1016/j.freeradbiomed.2023.08.032 [doi] PST - ppublish SO - Free Radic Biol Med. 2023 Nov 1;208:430-444. doi: 10.1016/j.freeradbiomed.2023.08.032. Epub 2023 Sep 1.